Kaptur Approps Amendment Directs HHS To Report On Drug Prices In Gov’t Programs

July 12, 2018
Rep. Marcy Kaptur (D-OH) is again trying to get HHS to provide an analysis of drug price increases, including rebates paid to middlemen, after a similar effort from two years ago did not return the results she had hoped. Kaptur gained bipartisan support for an amendment to the HHS 2019 spending bill that directs HHS agencies to report on changes in drug prices across Medicare Part B and Part D, Medicaid and the Veterans Affairs Department. The amendment was added...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.